OWL

Blue Owl Capital to Offer 10-Year Senior Notes

Blue Owl Capital Inc. has announced its intention to offer 10-year senior unsecured notes through its subsidiary, Blue Owl Finance LLC. The notes will be fully and unconditionally guaranteed by several entities within the Blue Owl Capital Inc. umbrella. The net proceeds from this offering will be used to repay a portion of outstanding borrowings under its revolving credit facility, with any remaining proceeds allocated to general corporate purposes, including potential future strategic acquisitions or growth initiatives.

The notes will be offered to qualified institutional buyers and non-U.S. persons outside the United States, and will not be registered under the Securities Act or any state securities laws. Blue Owl Capital Inc. also intends to enter into a registration rights agreement in connection with the offering of the notes.

As of December 31, 2023, Blue Owl Capital Inc. had over $165 billion in assets under management, investing across three multi-strategy platforms: credit, GP strategic capital, and real estate. The company aims to provide private capital solutions for businesses and offer differentiated alternative investment opportunities to institutional and individual investors.

It's evident that Blue Owl Capital Inc. is actively seeking to bolster its financial position and capitalize on potential growth opportunities through this senior notes offering. With a significant asset base and a focus on delivering strong performance and risk-adjusted returns, the company is positioning itself for continued success in the alternative asset management space. As a result of these announcements, the company's shares have moved -1.1% on the market, and are now trading at a price of $18.66. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS